UpdatesPress Release
Vimta Labs posted record Q2 revenue of 104.5 Cr, up 22.3% YoY.
Vimta Labs LimitedVIMTALABS · Filed with the exchange
EBITDA margin was 35.3%, PAT margin 19.1%. H1 revenue reached 203.8 Cr, up 26.6%. Growth driven by Pharma and Food testing services.
The company also achieved a successful WHO audit for Clinical Research.
No comments yet. Be the first.